KFDA warns pediatric suicide risk on 208 antidepressants

Published: 2007-05-18 06:57:00

Updated: 2007-05-18 06:57:00

The Korea Food and Drug Administration said on May 15 it instructed pharmaceutical firms to attach a stricter warning about the risk of suicide in pediatric patients when labeling antidepressants.

Manufacturers of 208 antidepressants, including Paxil, CR will be obliged to attach warnings that...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK